Trending News

State Department Issues New, Immediate Requirement for Nonimmigrant Visa Applicants

Adjudicating Nonimmigrant Visa Applicants in Their Country of Residence — Implications for Employers and Employees

District Court Rejects First Amendment Challenge to California Climate Disclosure Requirements

This Week in 340B: August 5 – 11, 2025

DOL Resurrects PAID Program to Supervise Employers’ Self-Audits and Settlements of Potential FLSA and FMLA Violations

Trump Administration Issues AI Action Plan and AI Executive Orders

Winning the Race: America’s AI Action Plan

Innovation Over Regulation – Trump Unveils America’s AI Action Plan

Caught in the Act: Practical and Legal Considerations When Executives’ Office Love Affair Exposed

Florida’s CHOICE Act Becomes Law, Enhancing Certain Non-Compete Agreements

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

FOXO TECHNOLOGIES INC. ANNOUNCES REVERSE STOCK SPLIT
Posted On Thursday, July 17, 2025
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Posted On Thursday, July 17, 2025
NKGen Biotech and HekaBio Enter Strategic Partnership to Bring Novel NK Cell Therapy to Japan
Posted On Thursday, July 17, 2025
Updated Data from Eledon Pharmaceuticals’ Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation to be Presented at the World Transplant Congress 2025
Posted On Thursday, July 17, 2025
Oncotelic Therapeutics Highlights Peer‑Reviewed Publication Linking TGFB2 to Survival in Younger Pancreatic Cancer Patients
Posted On Thursday, July 17, 2025
SPR to Feature Five Abstracts on SPRINT® PNS at ASPN 2025
Posted On Thursday, July 17, 2025
Tevogen Signs Letter of Intent for New In-House Cell Therapy Manufacturing Facility
Posted On Thursday, July 17, 2025
Creative Medical Technology Holdings Receives Notice of Allowance for the Prevention and/or Treatment of Type 1 Diabetes Using Modulated Immune Cells
Posted On Thursday, July 17, 2025
Adventure Awaits: Make-A-Wish® Central and Northern Florida Makes Jeremy’s Dream Come True with a Thrilling Mexican Sport Fishing Adventure
Posted On Thursday, July 17, 2025
Actuate Therapeutics Advances Clinical Program in Ewing Sarcoma After Positive Phase 1 Trial Demonstrates Complete and Partial Responses in Difficult-to-Treat Pediatric Sarcomas
Posted On Thursday, July 17, 2025
Vericel to Report Second-Quarter 2025 Financial Results on July 31, 2025
Posted On Thursday, July 17, 2025
Vor Bio Appoints Qing Zuraw, M.D. as Chief Development Officer
Posted On Thursday, July 17, 2025
Moleculin Engages Industry Veteran Adriano Treve to Explore Accelerated Strategic Partnerships
Posted On Thursday, July 17, 2025
60 Degrees Pharmaceuticals and Tulane University Sign Research Agreement to Study Tafenoquine Against Lyme and Bartonella Bacteria
Posted On Thursday, July 17, 2025
Praxis Precision Medicines Receives FDA Breakthrough Therapy Designation for Relutrigine for the Treatment of Seizures Associated with SCN2A and SCN8A Developmental and Epileptic Encephalopathies
Posted On Thursday, July 17, 2025
Lisata Therapeutics and WARPNINE Announce iLSTA Trial Enrollment Completion and Provide Preliminary Data Update
Posted On Thursday, July 17, 2025
BioAtla Announces Upcoming Oral Presentation at the 2025 European Society for Medical Oncology (ESMO) TAT Asia Meeting
Posted On Thursday, July 17, 2025
Hyperion DeFi to Host Corporate Update Event to Discuss Strategic Evolution from Eyenovia and the Future of On-Chain Finance on July 29, 2025
Posted On Thursday, July 17, 2025
Keros Therapeutics Announces the First Patient Dosing in the Phase 3 RENEW Clinical Trial of Elritercept
Posted On Thursday, July 17, 2025
INVO Fertility Announces a 1:3 Reverse Stock Split Effective Pre-Market Opening on July 21, 2025
Posted On Thursday, July 17, 2025
Repligen to Report Second Quarter 2025 Financial Results
Posted On Thursday, July 17, 2025
Velocity Clinical Research Partners with Palantir to Solve Clinical Trials’ Payment Headache
Posted On Thursday, July 17, 2025
Clearside Biomedical Announces Plan to Explore Strategic Alternatives to Advance its Proprietary Suprachoroidal Space (SCS®) Delivery Platform and Promising Ophthalmology Pipeline
Posted On Thursday, July 17, 2025
BioStem Technologies Provides Comments on CMS CY 2026 Proposed Medicare Reimbursement Rule Changes for Skin Substitutes
Posted On Thursday, July 17, 2025
Harvard Bioscience Announces CEO Succession Plan & Appointment of Two New Independent Directors to Board
Posted On Thursday, July 17, 2025

Print